Information on the safety of medicines

Нагадування про ризики лікування та необхідність моніторингу та спостереження за пацієнтами, які застосовують лікарські засоби, що містять amiodarone (АМІОДАРОН, таблетки по 0,2г)

Reminder about restrictions on the use of antibacterial agents belonging to the class of fluoroquinolones

New Risk of Regurgitation development / heart valve failure associated with fluoroquinolones for systemic and inhalation use.

On amendments to the instruction leaflet for medical use of the medicinal product Gabapentin 300 mg hard capsules, 10 capsules in a blister, 2 blisters in a carton, the applicant/manufacturer: PJSC «Technolog».

On amendments to the instruction leaflet for medical use of the medicinal product Ciprofloxacin 250 mg tablets, 10 tablets in a blister or 900 tablets in blisters in a box; 500 mg tablets in a blister, 10 tablets in a carton or 700 tablets in a blister in a box; Levofloxacin (ЛЕВОФЛОКСАЦИН) 250 and 500 mg tablets, 10 tablets in a blister, 1 blister in a carton, the applicant/manufacturer: PJSC «Technolog».